What is Sutro Biopharma's PP&E (net)?

Sutro Biopharma (STRO) reported PP&E (net) of $9.36M in Q1 2026.

How has Sutro Biopharma's PP&E (net) changed year-over-year?

Sutro Biopharma's PP&E (net) decreased by 44.3% year-over-year, from $16.8M to $9.36M.

What is the long-term trend for Sutro Biopharma's PP&E (net)?

Over 5 years (2020 to 2025), Sutro Biopharma's PP&E (net) has grown at a -3.8% compound annual growth rate (CAGR), from $12.94M to $10.65M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Sutro Biopharma STRO PP&E (Net)

PP&E (Net) at other companies

PfizerPFE

$19.4B+5.8%

Gilead SciencesGILD

$5.64B+4.0%

RegenxbioRGNX

$101.87M-11.0%

XencorXNCR

$51.49M-12.4%

AnaptysBio, Inc.ANAB

$1.28M-26.5%

SchrodingerSDGR

$20.45M-10.9%

Other financials

Income statement

See full

Revenue$14.5M-16.5%

Operating income-$29.7M+56.7%

Net income-$38.5M+49.3%

EPS (diluted)-$2.94+67.6%

Balance sheet

See full

Cash & equivalents$73.7M-30.6%

Total debt$13.6M-36.3%

Total equity-$66.9M-159%

Total assets$242.0M-24.7%

Cash flow

See full

Operating cash flow-$42.3M+37.7%

CapEx--100%

Free cash flow-$42.3M+37.8%

Valuation

See full

Market cap$489.66M+624%

Enterprise value$429.61M-2,600%

P/S4.9×+3.9×

Profitability

See full

Operating margin-120%-48.6pp

Net margin-154.2%-56.7pp

FCF margin-152.2%-51.1pp

Returns & leverage

See full

Return on equity-234.2%—

Debt / equity0.5×+0.3×

Current ratio3.1×+1.0×

Where this comes from

Reported directly by Sutro Biopharma in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sutro Biopharma's PP&E (net)?: Sutro Biopharma (STRO) reported PP&E (net) of $9.36M in Q1 2026.
How has Sutro Biopharma's PP&E (net) changed year-over-year?: Sutro Biopharma's PP&E (net) decreased by 44.3% year-over-year, from $16.8M to $9.36M.
What is the long-term trend for Sutro Biopharma's PP&E (net)?: Over 5 years (2020 to 2025), Sutro Biopharma's PP&E (net) has grown at a -3.8% compound annual growth rate (CAGR), from $12.94M to $10.65M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.